RETROSENSE THERAPEUTICS
RetroSense Therapeutics is a biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) and advanced dry age-related macular degeneration (advanced dry-AMD). There are currently no FDA approved drugs to improve or restore vision in patients with these retinal degenerative conditions. The company's approach to using optogenetics in vision restoration is based on pioneering, proprietary research conducted at Wayne State University and Massachusetts General Hospital. Founded in 2009, RetroSense Therapeutics is headquartered in Ann Arbor, Michigan.
RETROSENSE THERAPEUTICS
Industry:
Biotechnology Genetics Life Science Therapeutics
Founded:
2009-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.retro-sense.com
Total Employee:
1+
Status:
Closed
Contact:
(734) 369-9333
Email Addresses:
[email protected]
Total Funding:
17 M USD
Technology used in webpage:
SPF Amazon Amazon Ohio Region NameBright
Current Advisors List
Current Employees Featured
Founder
Investors List
RBV Capital
RBV Capital investment in Series B - RetroSense Therapeutics
Blue Water Angels
Blue Water Angels investment in Series B - RetroSense Therapeutics
Santen Pharmaceutical
Santen Pharmaceutical investment in Series B - RetroSense Therapeutics
EG Capital Advisors
EG Capital Advisors investment in Series B - RetroSense Therapeutics
ExSight Ventures
ExSight Ventures investment in Series B - RetroSense Therapeutics
Michigan Economic Development Corporation
Michigan Economic Development Corporation investment in Series A - RetroSense Therapeutics
SDL Ventures
SDL Ventures investment in Series A - RetroSense Therapeutics
Tech Coast Angels
Tech Coast Angels investment in Series A - RetroSense Therapeutics
Nerveda
Nerveda investment in Series A - RetroSense Therapeutics
Blue Water Angels
Blue Water Angels investment in Series A - RetroSense Therapeutics
Official Site Inspections
http://www.retro-sense.com
- Host name: ec2-3-19-116-195.us-east-2.compute.amazonaws.com
- IP address: 3.19.116.195
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "RetroSense Therapeutics"
RetroSense Therapeutics - Crunchbase Company Profile & Funding
RetroSense Therapeutics is a biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa (RP) …See details»
Allergan Acquires RetroSense – ADEXILIS International
Allergan Acquires Gene Therapy Company RetroSense …
Sep 6, 2016 · RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness …See details»
RetroSense Therapeutics - VentureRadar
"RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis …See details»
Allergan Acquires Gene Therapy Company RetroSense Therapeutics
Sep 6, 2016 · Allergan plc, a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company focused on novel gene …See details»
RetroSense Therapeutics | F6S
Led by a team of seasoned veterans, RetroSense Therapeutics was founded in 2009 to develop a novel gene therapy approach to vision restoration. RetroSense is located in Ann Arbor, …See details»
RetroSense Therapeutics, LLC | Ann Arbor, MI, USA Startup - Gust
RetroSense is developing a novel gene therapy approach to vision restoration. Our management team has extensive experience across all aspects of the business and science of drug …See details»
RetroSense Therapeutics is Acquired by Allergan - Ann Arbor SPARK
Sep 7, 2016 · Ann Arbor-based RetroSense, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to restore vision in patients suffering from …See details»
RetroSense Therapeutics - Products, Competitors, Financials, …
RetroSense Therapeutics is a privately-held biotechnology company developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis …See details»
RetroSense Therapeutics - Funding, Financials, Valuation & Investors
RetroSense Therapeutics is a biotechnology company developing gene therapy for vision restoration.See details»
blog/the-retrosense-story-a-life-science-journey-to-success
RetroSense is developing life-enhancing gene therapies designed to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular …See details»
RetroSense Therapeutics - Contacts, Employees, Board Members, …
RetroSense Therapeutics is a biotechnology company developing gene therapy for vision restoration.See details»
RetroSense Therapeutics - LinkedIn
RetroSense is an agile company with a culture of flexibility, determination, and innovative thinking. RetroSense Therapeutics | 362 followers on LinkedIn. Led by a team of seasoned veterans,...See details»
Optogenetics startup RetroSense bought by Allergan for $60 million
Sep 6, 2016 · B iotech company RetroSense Therapeutics, which is developing a gene therapy for patients suffering from a form of blindness, is being acquired by Allergan for $60 million, …See details»
RetroSense Therapeutics’ investors see exit, bright future ahead
Sep 7, 2016 · An investment made by several groups of early-stage Michigan investors could pay off in a big way following the recent news that Allergan acquired Ann Arbor-based RetroSense …See details»
Allergan snaps up gene therapy startup to restore vision in rare ...
Sep 6, 2016 · Allergan ($AGN) has bought gene therapy startup RetroSense Therapeutics to gain an early clinical candidate to treat the rare vision disorder retinitis pigmentosa (RP). The aim is …See details»
Allergan Buys RetroSense Therapeutics for $60M+
Sep 6, 2016 · Allergan has acquired RetroSense Therapeutics for $60 million upfront-plus, the companies said today, in a deal that adds RetroSense’s Phase I/IIa gene therapy candidate …See details»
Wayne State University startup joins ranks of 50 smartest companies
Jun 21, 2016 · RetroSense Therapeutics is a privately held biotechnology company that develops life-enhancing gene therapies designed to restore vision in patients suffering from blindness …See details»
RetroSense Therapeutics - MIT Technology Review
Its therapy uses optogenetics, a technology that uses a combination of gene therapy and light to precisely control nerves. In its treatment of retinitis pigmentosa, the eye is injected with viruses...See details»
RetroSense Therapeutics - Tech Stack, Apps, Patents & Trademarks
RetroSense Therapeutics is a biotechnology company developing gene therapy for vision restoration.See details»